EUROPE VETERINARY VACCINES MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • EUROPE VETERINARY VACCINES MARKET FORECAST 2020-2028

EUROPE VETERINARY VACCINES MARKET FORECAST 2020-2028

 The European veterinary vaccines market is evaluated to reach a CAGR of 5.76% over the forecast period, 2020-2028. The growing prevalence of livestock diseases is one of the major factors contributing to the growth of the veterinary vaccines market in the region. The veterinary vaccines market in Europe is analyzed further by segmenting the region into countries such as France, Russia, the UK, Italy, Germany, Poland, Germany, and the rest of Europe.

EUROPE VETERINARY VACCINES MARKET FORECAST 2020-2028

Europe Veterinary Vaccines Market by Vaccine Type (Livestock Vaccine (Porcine Vaccine, Bovine Vaccine, Poultry Vaccine, Aquaculture Vaccine, Other Livestock Vaccine), Companion Vaccine (Canine Vaccine, Feline Vaccine, Equine Vaccine)) by Technology (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Toxoid Vaccine, Other Technology) by Disease (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Disease Type) by Geography.

Request free sample

The European veterinary vaccines market is evaluated to reach a CAGR of 5.76% over the forecast period, 2020-2028. The growing prevalence of livestock diseases is one of the major factors contributing to the growth of the veterinary vaccines market in the region.

The veterinary vaccines market in Europe is analyzed further by segmenting the region into countries such as France, Russia, the UK, Italy, Germany, Poland, Germany, and the rest of Europe. The United Kingdom has government and private partnership insurance schemes for cattle, which compensates for consequential losses. In the UK, the Cattle Health Welfare Group has an important role in addressing relevant cattle health and welfare issues. CHAWG acts as the first point of contact for all cattle health and welfare research, along with new disease challenges. In France, the veterinary vaccines market has observed strong growth owing to increasing public and private initiatives for animal welfare. With the increasing innovations and technological development in the field of veterinary vaccines, rising investments in this field are estimated to augment the growth of the French market. In countries like Germany, animal health is protected by legislation and veterinary administration. In 2015, Germany made a country-wide compulsory vaccination campaign against the bluetongue disease epidemic, which has reduced the new outbreaks. Moreover, a better understanding of the immunological and molecular disease processes of animals will help develop innovative vaccines, and therefore, boost the market in this region.

Ceva Santé Animale, headquartered in Libourne, France, is a global veterinary health company concentrating on the R&D, production and marketing of vaccines and pharmaceutical products for companion animals, livestock, swine, and poultry. The company has a partnership with biotecon diagnostics.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARIES
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    • KEY DRIVERS
      • PROGRESSION IN THE VACCINE PRODUCTS
      • INCREASING GOVERNMENT INITIATIVES
      • INCREASING INCIDENCE OF ZOONOTIC DISEASES
      • SURGE IN THE COMPANION ANIMAL OWNERSHIP
      • GROWING PREVALENCE OF LIVESTOCK DISEASES
    • KEY RESTRAINTS
      • HIGH COST OF VACCINATIONS
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • LACK OF SKILLED FARMWORKERS AND VETERINARIANS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE
  3. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • ANICON LABOR GMBH
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • ELANCO (ELI LILLY AND COMPANY)
    • HESTER BIOSCIENCES LIMITED
    • HIPRA
    • HYGIEIA BIOLOGICAL LABORATORIES
    • MERCK & CO.
    • PHIBRO ANIMAL HEALTH CORP.
    • ROMVAC COMPANY S.A.
    • VAXXINOVA GMBH-GERMANY
    • VIRBAC SA
    • ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE

TABLE 2: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: EUROPE LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: EUROPE LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: EUROPE PORCINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 10: EUROPE PORCINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 11: EUROPE BOVINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES

TABLE 13: EUROPE BOVINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 14: EUROPE POULTRY VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES

TABLE 16: EUROPE POULTRY VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 17: EUROPE AQUACULTURE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES

TABLE 19: EUROPE AQUACULTURE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 20: EUROPE OTHER LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: EUROPE OTHER LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 22: EUROPE COMPANION VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: EUROPE COMPANION VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 24: EUROPE COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: EUROPE COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 26: EUROPE CANINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 28: EUROPE CANINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 29: EUROPE FELINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 31: EUROPE FELINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 32: EUROPE EQUINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 34: EUROPE EQUINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 35: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 36: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 37: EUROPE LIVE ATTENUATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 38: EUROPE LIVE ATTENUATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 39: EUROPE INACTIVATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 40: EUROPE INACTIVATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 41: EUROPE RECOMBINANT VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 42: EUROPE RECOMBINANT VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 43: EUROPE TOXOID VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 44: EUROPE TOXOID VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 45: EUROPE OTHER TECHNOLOGY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 46: EUROPE OTHER TECHNOLOGY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 47: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 48: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 49: EUROPE CANINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 50: EUROPE CANINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 51: EUROPE PORCINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 52: EUROPE PORCINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 53: EUROPE BOVINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 54: EUROPE BOVINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 55: EUROPE POULTRY DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 56: EUROPE POULTRY DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 57: EUROPE AQUACULTURE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 58: EUROPE AQUACULTURE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 59: EUROPE OTHER DISEASE TYPE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 60: EUROPE OTHER DISEASE TYPE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 61: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 62: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, IN 2019

FIGURE 5: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 6: EUROPE LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 7: EUROPE LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 8: EUROPE LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 9: EUROPE LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 10: EUROPE LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 11: EUROPE VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 12: EUROPE COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 13: EUROPE COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 14: EUROPE COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 15: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, IN 2019

FIGURE 16: EUROPE VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 17: EUROPE VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 18: EUROPE VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 19: EUROPE VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 20: EUROPE VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 21: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, IN 2019

FIGURE 22: EUROPE VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 23: EUROPE VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 24: EUROPE VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 25: EUROPE VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 26: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 27: EUROPE VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)

FIGURE 28: EUROPE VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 29: THE UNITED KINGDOM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 30: FRANCE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 31: GERMANY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 32: ITALY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 33: RUSSIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 34: BELGIUM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 35: POLAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 36: REST OF EUROPE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now